Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients

Kidney International

Volumn 59, Issue 1, 2001, Pages 69-75

  Cohen, M L ^a   Douvdevani, A ^a   Chaimovitz, C ^a   Shany, S ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

CAPD; Cell growth; Cytokines; Immune system; Inflammation; Peritonitis; Vitamin D

Indexed keywords

CALCITRIOL; KETOCONAZOLE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERICIDAL ACTIVITY; CELL GROWTH; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOKINE RELEASE; DRUG EFFECT; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035170787     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00467.x     Document Type: Article

References (36)

1. Interaction of 1.25-dihydroxyvitamin D3 and the immune system
2. Annotation vitamin D and human leukemia
3. Differentiation of mouse myeloid leukemia cells induced by 1,25-dihydroxyvitamin D3
4. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients
5. Losses of 25-hydroxyvitamin D in peritoneal fluid: Peritoneal dialysis
6. Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: Changes in kinetics and in oxidase cytosolic factor p47
7. Immunological properties of vitamin D analogues and metabolites
8. Of 1,25-dihydroxyvitamin D on the immune activity of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients
9. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3: Specific inhibition at the level of messenger RNA
10. Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3
11. 3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 production
12. The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: Marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3
13. Differential expression of M-CSF, LIF, and TNF-alpha genes in normal and malignant rat glial cells: Regulation by lipopolysaccharide and vitamin D
14. 3: Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene
15. Vitamin D therapy modulates cytokine secretion in patients with renal failure
16. Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium
17. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients
18. 3
19. Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control
20. Simultaneous quantitation of cytokine mRNAs in interleukin-1 beta stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with an internal multi-specific control
21. A micro-assay for 1,25(OH)2D3, not requiring HPLC: Applications to clinical studies
22. Subcellular localization and partial purification of the 25-hydroxyvitamin D3, 1-hydroxylation reaction in the chick myelomonoctytic cell line HD-11
23. The immunobiology of vitamin D
24. Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury
25. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
26. Losses of 1, 25 and 24: 25-dihydroxycholecaliferol in the peritoneal fluid of patients treated with chronic ambulatory dialysis
27. Tumor necrosis factor (TNF)
28. Cachectin and tumour necrosis factor as two sides of the same biological coin
29. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation
30. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease
31. Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes
32. Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
33. Replaced therapy with monoclonal antibody to tumor necrosis factor alpha (cA2) in patients with rheumatoid arthritis
34. 3: In vivo and in vitro effects on human preleukemic and leukemic cells
35. 3 in growth regulation of cancer cell lines
36. 2, calcitriol, and calcipotriol